공지 : 도쿄증권거래소 JASDAQ 스탠다드 시장 신규 상장 관련 안내

Global Information
회사소개 | 문의 | 비교리스트

미결정 셀룰로오스(MCC) 시장 : 성장, 동향, 예측(2020-2025년)

Microcrystalline Cellulose Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)

리서치사 Mordor Intelligence Pvt Ltd
발행일 2021년 05월 상품 코드 963974
페이지 정보 영문
가격
US $ 4,250 ₩ 5,044,000 PDF (Single User License)
US $ 4,750 ₩ 5,637,000 PDF (Team License: Up to 7 Users)
US $ 6,000 ₩ 7,121,000 PDF (Site License)
US $ 7,500 ₩ 8,901,000 PDF (Corporate License)


미결정 셀룰로오스(MCC) 시장 : 성장, 동향, 예측(2020-2025년) Microcrystalline Cellulose Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)
발행일 : 2021년 05월 페이지 정보 : 영문

본 상품은 영문 자료로 한글과 영문목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

미결정 셀룰로오스 시장 규모는 예측기간 중 6% 이상의 CAGR로 성장할 것으로 예측됩니다. 시장을 견인하는 주요 요인의 하나는 세계의 중요한 경제권 전체에서 제약 업계로부터의 미결정 셀룰로오스에 대한 수요 증가입니다. 그러나 미결정 셀룰로오스의 높은 제조 비용은 시장 성장을 저해할 것으로 예상됩니다.

  • 최종 이용 산업별로는 제약 업계가 예측기간 중 시장을 독점할 것으로 예상됩니다.
  • 캔버스의 라이닝 접착제로서 미결정 셀룰로오스 복합재료 수요 증가는 향후 몇 년간 시장 기회로서 기능할 가능성이 있습니다.
  • 아시아태평양은 인도나 중국 등의 국가에서 제약 업계로부터의 제조 증가로 시장을 독점할 것으로 예상됩니다.

세계의 미결정 셀룰로오스(Microcrystalline Cellulose) 시장을 조사했으며, 시장 개요, 시장 성장 촉진요인 및 저해요인 분석, 시장 기회, 원료·프로세스·최종 이용 산업·지역별 시장 규모 추정과 예측, 경쟁 상황, 주요 기업 개요 등 체계적인 정보를 제공합니다.

목차

제1장 서론

제2장 조사 방법

제3장 주요 요약

제4장 시장 역학

  • 성장 촉진요인
    • 제약 업계로부터의 수요 증가
    • 기타
  • 성장 억제요인
    • 높은 제조 비용
    • 기타
  • 밸류체인 분석
  • Porter's Five Forces 분석
  • 프로세스 분석

제5장 시장 세분화

  • 원료별
    • 목재 기반
    • 비목재 기반
  • 프로세스별
    • 반응성 압출
    • 효소 매개
    • 증기 폭발
    • 산가수분해
  • 최종 이용 산업별
    • 제약
    • 식품
    • 화장품
    • 기타
  • 지역별
    • 아시아태평양
    • 북미
    • 유럽
    • 남미
    • 중동과 아프리카

제6장 경쟁 상황

  • 합병과 인수, 합작투자, 협업, 합의
  • 시장 점유율/순위 분석**
  • 주요 기업이 채용한 전략
  • 기업 개요
    • Chemfield Cellulose
    • Accent Microcell Pvt. Ltd
    • FMC Corporation
    • Sigachi Industries Pvt. Ltd
    • DuPont
    • MINGTAI CHEMICAL CO. LTD
    • Asahi Kasei Corporation
    • Juku Orchem Pvt. Ltd
    • J. Rettenmaier & Sohne GmbH + Co. KG
    • Huzhou City Linghu Xinwang Chemical Co. Ltd
    • Avantor Performance Materials Inc.
    • DFE Pharma GmbH & Co.KG
    • Blanver
    • Gujarat Microwax Limited
    • FrieslandCampina

제7장 시장 기회와 동향

  • 캔버스의 라이닝 접착제로서 미결정 셀룰로오스 복합재료 수요 증가
  • 기타 기회
KSM 20.10.30

The Global Microcrystalline Cellulose Market is projected to register a CAGR of over 6% during the forecast period (2021-2026).

Pharmaceutical and cosmetics are the major end-user industries of microcrystalline cellulose. The ongoing coronavirus (COVID-19) pandemic has altered the face of the beauty industry. As a result of months of consumer lockdowns, international travel bans, and retail business closures, sales, purchases, and usage have fallen across many beauty segments. However, the pharmaceutical industry experienced an increase in production due to the COVID-19 pandemic as the medicines used in hospitals around the world have increased thus increasing the demand for microcrystalline cellulose which is used in the production of drugs. Furthermore, government support in various countries in the pharmaceutical sector is expected positively influence the market studied. For instance, in 2021, in India, the government has approved 19 applications with committed investments of INR 4623.01 crore under the Production Linked Incentive (PLI) Scheme for Promotion of Domestic Manufacturing of critical Key Starting Materials (KSMs)/ Drug Intermediates and Active Pharmaceutical Ingredients (APIs).

  • Over the short term, the growing demand for microcrystalline cellulose from the pharmaceutical industry across significant economies of the world is expected to drive the demand for the market studied.
  • On the flipside, the high manufacturing and production cost of microcrystalline cellulose is expected to hinder the growth of the market studied.
  • The Asia-Pacific region is expected to dominate the market with increasing manufacturing from the pharmaceutical industry in countries like India and China.

Key Market Trends

Increasing Demand from Pharmaceutical Industry

  • Microcrystalline cellulose (MCC) is a pure partially depolymerized cellulose synthesized from α-cellulose precursor (type IB), obtained as a pulp from fibrous plant material, with mineral acids using hydrochloric acid to reduce the degree of polymerization.
  • Microcrystalline cellulose is a commonly used excipient in the pharmaceutical industry. It has excellent compressibility properties and is used in solid dose forms, such as tablets, and is the most widely used direct compression excipient, acting as a strong dry binder, tablet disintegrant, absorbent, filler or diluent, lubricant, and anti-adherent.
  • MCC is widely regarded as the diluent with the best binding properties, and it is one of the most commonly used direct compression binders.
  • It is used as a binder/diluent in both wet granulation and direct compression processes for oral tablet and capsule formulations. It also has lubricant and disintegrant properties, making it ideal for direct tableting.
  • The factors such as disease prevalence, affordability, consumer's attitude, government (and insurance company) policies, and available supply of medicines boost the pharmaceutical industry, which, in turn, increases the demand for microcrystalline cellulose.
  • Global pharmaceutical industry is increasing with growing production in countries such as United States, China and India. India is a prominent and rapidly growing market for pharmaceuticals. It has largest number of US-FDA compliant Pharma plants (more than 262 including APIs) outside of USA and has more than 2000 WHO-GMP approved Pharma Plants, 253 European Directorate of Quality Medicines (EDQM) approved plants with modern state of the art Technology.
  • Moreover, the companies are also planning to invest across the globe amid increasing demand of pharmaceuticals worldwide. For instance, in December 2020, an Indian company, Piramal Pharma Solutions announced its plans to invest USD 32 million to expand its facility in Michigan, the United States, with additional capacity and new capabilities for development and manufacturing of active pharmaceutical ingredients.
  • Hence, owing to the factors mentioned above, the application of microcrystalline cellulose from the pharmaceutical industry is likely to increase during the forecast period.

Asia-Pacific to Dominate the Market

  • The Asia-Pacific region is expected to dominate the market during the forecast period. The rising demand for microcrystalline cellulose from pharmaceutical and cosmetics industries in countries like China and India is expected to drive the demand for microcrystalline cellulose in this region.
  • According to Invest India, the pharmaceutical industry in India is expected to reach USD 65 billion by 2024 and is currently valued at USD 41 billion.
  • The largest producers of microcrystalline cellulose are based in the Asia-Pacific region. Some of the leading companies in the production of microcrystalline cellulose are Sigachi Industries Pvt. Ltd, Huzhou City Linghu Xinwang Chemical Co. Ltd, DuPont, Asahi Kasei Corporation, and J. Rettenmaier & Sohne GmbH + Co. KG, among others.
  • According to L'Oreal data, the global cosmetic market, which is valued at more than EUR 220 billion, grew by more than 5.5% in 2019, with sales from online platforms gaining the highest momentum, of more than 25% during the same year. This growth is majorly spurred on in the Asia-Pacific region by the limitless diversity of consumer aspirations and owing to the continuous innovations in the industry. Asia-Pacific has the highest demand for cosmetics, particularly luxury products. The region accounted for over half of the skincare market.
  • South Korea has one of the world's most exceptional beauty markets. New beauty trends and innovations, featuring sophisticated ingredients and aesthetically-appealing packaging, are constantly on display. The South Korean cosmetics products market was valued at USD 1,578.4 million in 2019, and it is expected to reach USD 1952.05 million by 2025 during the forecast period, 2020-2025.
  • Owing to the factors mentioned above, the market for microcrystalline cellulose in the Asia-Pacific region is projected to grow significantly during the study period.

Competitive Landscape

The microcrystalline cellulose market is partially fragmented in nature, with only a few major players dominating the market. Some of the major companies of the market studied include DuPont, Chemfield Cellulose, Accent Microcell, Sigachi Industries Limited, and DFE Pharma, among others.

Reasons to Purchase this report:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Drivers
    • 4.1.1 Growing Demand for Microcrystalline Cellulose from Pharmaceutical Industry
    • 4.1.2 Other Drivers
  • 4.2 Restraints
    • 4.2.1 High Manufacturing and Production Cost
    • 4.2.2 Impact of COVID-19 on Cosmetics Industry
  • 4.3 Industry Value Chain Analysis
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Degree of Competition
  • 4.5 Process Analysis

5 MARKET SEGMENTATION

  • 5.1 Source
    • 5.1.1 Wood-based
    • 5.1.2 Non -wood-based
  • 5.2 Process
    • 5.2.1 Reactive Extrusion
    • 5.2.2 Enzyme Mediated
    • 5.2.3 Steam Explosion
    • 5.2.4 Acid Hydrolysis
  • 5.3 End-User Industry
    • 5.3.1 Pharmaceutical
    • 5.3.2 Food
    • 5.3.3 Cosmetics
    • 5.3.4 Other End-User Industries
  • 5.4 Geography
    • 5.4.1 Asia-Pacific
      • 5.4.1.1 China
      • 5.4.1.2 India
      • 5.4.1.3 Japan
      • 5.4.1.4 South Korea
      • 5.4.1.5 Rest of Asia-Pacific
    • 5.4.2 North America
      • 5.4.2.1 United States
      • 5.4.2.2 Canada
      • 5.4.2.3 Mexico
    • 5.4.3 Europe
      • 5.4.3.1 Germany
      • 5.4.3.2 United Kingdom
      • 5.4.3.3 France
      • 5.4.3.4 Italy
      • 5.4.3.5 Rest of Europe
    • 5.4.4 South America
      • 5.4.4.1 Brazil
      • 5.4.4.2 Argentina
      • 5.4.4.3 Rest of South America
    • 5.4.5 Middle-East and Africa
      • 5.4.5.1 Saudi Arabia
      • 5.4.5.2 South Africa
      • 5.4.5.3 Rest of Middle-East and Africa

6 COMPETITIVE LANDSCAPE

  • 6.1 Mergers and Acquisitions, Joint Ventures, Collaborations, and Agreements
  • 6.2 Market Share(%)** /Ranking Analysis
  • 6.3 Strategies Adopted by Leading Players
  • 6.4 Company Profiles
    • 6.4.1 Accent Microcell
    • 6.4.2 Asahi Kasei Corporation
    • 6.4.3 Blanver
    • 6.4.4 Chemfield Cellulose
    • 6.4.5 DFE Pharma
    • 6.4.6 DuPont
    • 6.4.7 GUJARAT MICROWAX PVT. LTD.
    • 6.4.8 Huzhou City Linghu Xinwang Chemical Co., Ltd
    • 6.4.9 J. RETTENMAIER & SOHNE GmbH + Co KG
    • 6.4.10 JUKU ORCHEM PVT. LTD.
    • 6.4.11 MINGTAI CHEMICAL CO., LTD
    • 6.4.12 Sigachi Industries Limited
    • 6.4.13 VWR International, LLC (Avantor, Inc.)

7 MARKET OPPORTUNITIES AND FUTURE TRENDS

  • 7.1 Growing Demand of Microcrystalline Cellulose Composites as Lining Adhesives for Canvas
  • 7.2 Other Opportunities
Back to Top
전화 문의
F A Q